Two species of Panax (P. quinquefolius and P. trifolius L.) are native to North America. The latter species is much smaller and rarely used for medicinal purposes. There are 11 species globally, several of which are Asian, most notably P. ginseng C.A.Mey. known as Korean or Asian ginseng.
pseudoginsenoside is found only in P. quinquefolius (Leung & Wong, 2010) . Another class of dammarane-type triperpene oligoglycosides (quinquenosides I-V) are also found in the species (Yoshikawa et al., 1998) .
A wide range of extraction, separation and detection methods have been applied for the determination of ginsenoside structures and levels in different plant sections. These methods include high-performance liquid chromatography (HPLC), mass spectroscopy (MS), diode-array detectors (DAD), infra-red (IR) spectroscopy and evaporative light scattering detection (ELSD) (Ferreira, Ebbs, Murphy, & Corbit, 2005; Jia, Zhao, & Liang, 2009; Orsat & Dai, 2010; Qi, Wang, & Yuan, 2011; Wan, Li, Chen, & Wang, 2007; Yat et al., 1998) . The United States Monograph (USP, 2004) includes TLC and HPLC methods for ginsenoside evaluation, with the acceptable total content being no less than 4% of the dried roots (USP, 2004) . Modifications to the USP methods have been recommended, in an attempt to overcome inconsistent results observed from the use of different HPLC columns (Li, Chen, Chou, Want, & Hu, 2004) . For identity of pseudoginsenoside F11, HPLC was coupled with ELSD (Li & Fitzloff, 2001 ).
Using ultra-performance LC linked with MS for separation and identification, G. Xie et al (2008) further analyzed five ginseng species by principal component analysis and found that P. quinquefolius was readily discriminated from the other four species tested. Gene sequencing experiments have also led to an understanding of the biosynthesis of ginsenosides; the genes encoding enzymes identified include 150 cytochrome P450 and 235 glycosyltransferase sequences unique to P. quinquefolius (Sun et al., 2010) .
Ginsenosides are classified into two main groups known as protopanaxadiol (PPD) and protopanaxatriol (PPT), based on the hydroxylation pattern at C6 and attachment of sugar moieties (Table 1) . Phytochemically Panax species are distinguished by the ratio between these groups (Hall, Lu, Yat, Fitzloff, et al. 2001) . For example P. ginseng ginsenosides are mainly of the PPD group, while PPTs are more prominent in P. quinquefolius although Rf is entirely absent. Further differentiation may be made by the ratios of Rg1/Rb1 and Rb2/Rb1 which tend to be higher in P. ginseng (Yuan, Wang, Wicks, & Qi, 2010) although some wild populations of P. quinquefolius have been found to have high Rg1/Rb1 ratios (Schlag & McIntosh, 2006) . As a generalization the most prominent P. quinquefolius constituents are Rb1 and Re (Assinewe et al., 2003) . However North America P. quinquefolius populations have been further differentiated according to their Rg1/Re ratio (Schlag & McIntosh, 2006; McIntyre et al. 2011) . The variation in chemotypes is not only significant for identification purposes -they also have clinical implications as discussed below under metabolism. The main ginsenosides in P. quinquefolius are listed in Table 2 . Table 1 . Classification of ginsenosides in Panax spp. (Leung & Wong, 2010) . Compounds are named according to a decreasing polarity scale (i.e.water solubility). Generally the PPT group is more polar due to the extra hydroxyl group e.g. Re, while the less polar PPDs tend to be lower in the alphabet eg. Rb. Ginsenoside content will also vary as a consequence of increased temperatures. P. quinquefolius grown at high temperatures tends to accumulate less biomass and develop smaller roots, leading to a reduction in total ginsenoside content (though not concentration) in plants subjected to a 5°C increase in growth temperatures in comparison to controls (Jochum, Mudge, & Thomas, 2007) . Preferential selection of larger roots for analysis of ginsenosides and polyacetylenes did not influence the concentrations of either group of constituents (Christensen & Jensen, 2008) . Ginsenoside levels are not influenced by root shape or section harvested, although root "fibre" has higher concentrations -though not of Rb1 (Roy, Grohs, & Reeleder, 2003) . Other factors that may act as predictors of ginsenoside concentration are age and stage of plant development, soil pH, light concentration (Schlag, 2004) and understory light levels including the effect of sun flecks (Fourniera et al, 2003) , while variation may also be found between cultivated, wild and wild-simulated plant material -this in turn is influenced by the seed source (Schlag, 2004) . Exposure of the roots to soil-borne heavy metals such as lead and arsenic can also influence ginsenoside production in ginseng roots (Corbit, Ebbs, King, & Murphy, 2006) .
Protopanaxadiol group (PPD)
In a surprise finding, J.-T. revealed that for Wisconsin cultivated P. quinquefolius the leaves contain far higher levels of ginsenosides (15.3%) compared to the berries (10.8%) and root (5.5%), and the ratio of the leaf components also differed, with particularly high concentrations of Rd and Re. By contrast Assinewe et al (2003) found the leaves of seven wild populations to contain only 3.33% ginsenosides compared with 5.78% for root.
Huge variability exists between different ginseng commercial products, partly due the number of species marketed as ginseng, as well as differences within products from the same species (Harkey, Henderson, Gershwin, Stern, & Hackman, 2001) . In an attempt to identify mislabeled and adulterated products marketed as ginseng in North America, and to develop a set of standardized tests for identity and quality, the American Botanical Council initiated the Ginseng Evaluation Program in collaboration with the Universities of Ottawa and Chicago (Hall, Lu, Fitzloff, Arnason, Awang, Fong, & Blumenthal, 2001 ).
Pharmacokinetics
There have been few pharmacokinetic investigations into P. quinquefolius. Those available are based around the ginsenosides, which are found to be of low bioavailability (Jia et al., 2009; Reeds et al., 2011) . This is partly a result of the first-pass metabolism that occurs, leading to formation of metabolites which may in fact be more potent that the ginsenoside "pro-drugs" from which they derive (Bae et al., 2004) .
Ginseng saponins appear to be readily degraded under mild acid conditions such as found in the human stomach. For example ginsenosides Rg1, Re and Rb1 were shown to yield their prosapogenins under such conditions (Han et al., 1982) . In further studies Bae, Han, Choo, Park, and Kim (2002) demonstrated the formation of ginsenoside Rg3 following mild acid treatment. This Rg3 metabolite was further transformed by human intestinal bacteria to Rh2, which showed increased cytotoxicity against tumor cells and Heliobacter pylori in vitro. Ginsenoside Rb1 occurs in both an acid form (malonyl-Rb1) and the neutral form, which in cultivated P. quinquefolius are in approximately equal proportions (Awang, 2000) . The acidic form can be converted to neutral Rb1 by steaming or by digestion in the stomach, after which it is further converted by anerobic bacterial enzymes to a more polar and more active metabolite -Rd ( Kim, Lee, & Lee, 2005) . Removal of glucose units from Rd by intestinal bacteria leads to formation of Intestinal Bacterial Metabolite (IBM) also called compound K -this unit can be absorbed into the bloodstream (Awang, 2000) . Ginsenosides Rb2, Rc and Rd follow a similar route.
Ginseng metabolites have also been shown to have more significant cytochrome P450 influence compared to the natural saponins . These studies provide further evidence that ginsenosides actually act as pro-drugs, which depend on transformation by stomach acid and intestinal bacteria to release their active constituents (Bae, Han, Kim, & Kim, 2004) . For a flow chart that displays the stages of biotransformation of the various ginsenosides by intestinal microflora to their metabolites, see Leung & Wong (2010) .
In addition to first pass effect, ginsenoside profiles may also be influenced by steaming ginsenga common tradition in Asia. HPLC profile comparisons between steamed and unsteamed P. quinquefolius roots have been published . When berries were steamed in a separate study, the overall level of ginsenosides was reduced however there was significant augmentation of Rg3, a recognized anticancer agent (Wang et al., 2006) . Rg3 has also been identified in heat-processed P. ginseng (Bae, et al. 2002) .
Polyacetylenes
Polyacetylenes are small lipid soluble molecules of limited distribution in plants. The major such compounds in P. quinquefolius roots are the alcohols falcarinol and panaxydol (Christensen, Jensen, & Kidmose, 2006) , while others include PQ-1→ PQ-8 (all previously unknown), panaxytriol, acetylpanaxydol and ginsenoyne G (Fujimoto, Satoh, Takeuchi, & Kirisawa, 1991; Fujimoto, Wang, Kirisawa, Satoh, & Takeuchi, 1992; Fujimoto, Wang, Satoh, & Takeuchi, 1994; Satoh et al., 2007) and a recently discovered compound 3-oxy-PQ-1 (Satoh et al., 2007 (Shan, Rodgers, Lai, & Sutherland, 2007) .
Other constituents
Apart from saponins P. quinquefolius contains phenolic compounds, amino acids, flavonoids, volatile oils, vitamins and minerals (Schlag, 2004; Jia et al, 2009; Qi, Wang, & Yuan, 2011) .
Pharmacology

Pharmacology of ginsenosides
As mentioned above, individual ginsenosides provide significantly different pharmacological effects, hence the interest in ascertaining specific levels and ratios. This is exemplified by the two major ginsenosides -Rb1 and Rg1 -characteristic of P. quinquefolius and P. ginseng respectively. Rb1 tends to be more of a depressant (more "yin", eg inhibiting angiogenesis) while Rg1 is a mild stimulant (more "yang", eg. promoting angiogenesis) (Harkey et al., 2001; Sengupta et al., 2004) . Further correlations between individual ginsenosides and their activities are listed in Table 3 . Effects on blood sugar and metabolism Numerous studies indicate that P. quinquefolius reduces postprandial glycemia in diabetic and non-diabetic human subjects in doses as low as 1g, suggesting a possible role for this species in complementing existing diabetic treatment (Vuksan et al., 2000a; Vuksan et al, 2000b; Vuksan et al, 2001 ). However, in one case when a different batch of P. quinquefolius from the same supplier -but with a much lower ginsenoside profile -was tested, no such effect was observed (Sievenpiper, Arnason, Leiter, & Vuksan, 2003) . In a separate study using P. ginseng no hypoglycemic effects were shown, rather there was a tendency towards elevated glucose (Sievenpiper et al., 2003) . This finding was confirmed in a subsequent study of several species and types of ginseng in which the ginsenoside ratio (PPD:PPT) is posited as a significant factor in the variable glycemic response (Sievenpiper, Arnason, Leiter, & Vuksan, 2004 ). Yet in a recent study using five batches of Ontario-grown P. quinquefolius reduced postprandial glycemia and insulinemia were shown for three of the batches but not for the other two, and variations in ginsenoside content did not correlate with these differences (Dascalu et al, 2007) . Studies in animals using P. quinquefolius leaves with high ginsenoside levels (referred to above) also demonstrated marked anti-hyperglycemic activity (J.-T. , and similar results have been obtained using berry extracts of both P. quinquefolius and P. ginseng (Attele et al., 2002; J-T Xie, Mehendale, & Yuan, 2005) . In a recent in vivo antidiabetic screening study of ninety botanical species, all three P. quinquefolius products (rhizome, leaf, berry) tested positive for lipogenic activity, however P. ginseng did not (Babish et al, 2010) . Lipogenesis improves insulin sensitivity as new adipocytes take up more glucose and secrete fewer detrimental cytokines compared to the larger adipocytes they replace (Babish et al., 2010) . Ginsenoside E has been identified as a specific hypoglycemic agent (Attele et al., 2002) although to date studies in humans do not support this effect (Reeds et al., 2011) .
Ginsenoside Rb1 also suppressed food intake and body weight gain in obese rats, while improving glucose homeostasis. Modulation of associated signaling pathways and neuropeptides in the hypothalamus was observed (Xiong et al., 2010) . Further studies with mice treated with polysaccharides extracted from the fruit suggest the polysaccharides are another potential component associated with anti-hyperglycemic activity for P. quinquefolius ).
Molecular studies based on P. ginseng indicate ginsenosides suppress gene expression associated with the nuclear hormone receptors peroxisome proliferator-activated receptors (PPAR) in vitro and in vivo (Yoon et al., 2003; Banz et al., 2007) . Furthermore, a specific ginsenoside Rb1 has been found to activate PPARγ -a transcription factor in adipogenesis -and increase expression of glucose transporters (GLUT) 1 and 4 in vitro. PPAR regulation has been linked to improved insulin sensitivity and reductions of lipid accumulation in muscle and liver (Banz et al., 2007) PPARs are also molecular targets for the anti-diabetic drugs known as TZDs (Kyu et al., 2006) .
In sum these studies confirm a marked benefit on glycemic profiles at low doses for P. quinquefolius but the benefits for P. ginseng species are less consistent. While differences in ginsenoside levels and their ratios may influence the efficacy of P. quinquefolius it would appear that other components may also be involved (Sievenpiper et al., 2004) .
Diabetic renal damage
Animal studies suggest that heat-processed P. quinquefolius (H-AG) extracts may have beneficial effects on renal damage associated with diabetic nephropathy. H-AG significantly decreased elevated urinary protein levels in streptozotocin (STZ)-induced diabetic rats, increased creatinine clearance and significantly reduced accumulation of advanced glycation endproducts (AGE) -a weaker effect on AGE was found with the unprocessed P. quinquefolius extract (H. Y. Kim, Kang, Yamabe, Nagai, & Yokozawa, 2007) .
Cardiovascular effects
Preliminary studies on rats have demonstrated potential cardioprotective, anti-ischemic, antioxidant, calcium channel blocking and platelet aggregate moderating effects of P. quinquefolius . Four months of dietary supplementation decreased oxidation damage to heart and muscle fibres with P. quinquefolius powder in rats (Fu & Ji, 2003) . Promotion of angiogenesis to infarcted or ischemic regions by an extract high in saponins was shown to provide cardioprotection in vivo (Wang, Shi, & Yin, 2007) . Ginseng species have ambiguous effects on angiogenesis -promoting wound healing on the one hand (dependent on angiogenesis) and inhibiting tumor growth via an antiangiogenic action on the other (Sengupta et al., 2004) . These contrasting properties have been linked to specific ginsenosides (Rb1 as inhibitor and Rg1 as inducer of angiogenesis respectively). Rb1 angiogenesis inhibition has been linked to agonistic effect on estrogen receptor β (Papapetropoulos, 2007) .
Memory and cognition
In contrast to the mild central nervous system (CNS) stimulant effects of P. ginseng, P. quinquefolius has a calming influence on the CNS . There is a great deal of evidence demonstrating that ginseng species in general and specific ginsenosides have multiple effects in the CNS, an affinity for a wide range of receptors in the CNS and specific influence on hippocampal neurons Jia et al., 2009) . Animal studies show cognitive enhancing and neuroprotective actions for P. quinquefolius, and specifically for ginsenosides Rb1 and Rg1 -though possibly via different mechanisms (Benishin et al., 1991; Rudakewich et al., 2001 ). Rb1 facilitated release of acetylcholine from the hippocampus and increased choline in nerve endings (Benishin et al., 1991) . Rb1, and to a less extent Rg1, extended the survival time of dopaminergic neurons against a selective neurotoxin (Radad et al., 2004) . There is a particular focus on the use of ginseng products for prevention and treatment of degenerative brain disorders such as Parkinson"s and Alzheimer"s diseases (Jia et al., 2009; Radad et al., 2006; Rausch et al., 2006) .
Common cold and immunity
Polysaccharide-rich extracts have been found to increase proliferation of spleen cells and macrophage activity in cell cultures as well as stimulate immunoglobulin G (IgG) in vivo and tumor necrosis factor (TNF) production from macrophages (Assinewe et al, 2002; Wang et al., 2001) . Increased TNF-production also occurred in blood samples of three human volunteers following intake of P. quinquefolius (Zhou & Kitts 2002) . CVT-E002-a water soluble extract standardized for polysaccharides, is marketed under the patented name COLD-fX for the treatment of upper respiratory tract infections and has been subjected to several clinical investigations (see "Clinical Studies' section below).
Mechanisms of anti-inflammatory activity have also been studied. Treating murine macrophages with P. quinquefolius extract quantified to contain 10% ginsenosides, LPS-induced nitrous oxide (iNOS) expression was inhibited, apparently by suppression of signal transducer and activator of transcription (STAT) cascade (Ichikawa et al., 2009) .
Cancer
There has been considerable interest in the potential use of ginseng in cancer for many decades.
Initially this interest focused mainly on using P. ginseng as an adjuvant to enhance efficacy and reduce side-effects of active cancer therapies such as chemotherapy and radiotherapy -based on the herb's reputation as an "adaptogenic" agent (Jia et al., 2009) . During the last decade there have been numerous investigations into the potential for P. quinquefolius to assist in the prevention and treatment of various forms of cancer.
Qi et al (2010) have explored potential structure-function relationships of ginsenosides in P. quinquefolius, identifying a number of possible cancer-prevention mechanisms including cell cycle modification, induction of apoptosis, and inhibition of angiogenesis and pro-inflammatory pathways. For a comprehensive review of studies and mechanisms involving ginseng and cancer see Jia et al. (2009) .
Breast cancer Using the standardized extract CNT-2000, studies on ER positive breast cancer cells showed dose-dependent decreases in cell and paradoxically an ability to induce expression of the estrogen-related gene pS2. There was no interference with the estrogen antagonist drug Tamoxifen when used concurrently, suggesting the possibility for synergistic interactions with conventional breast cancer agents (Duda et al., 1999) . In a subsequent study the CNT-2000 extract was found to be an inducer of the p21 protein, a universal cell cycle inhibitor, in estrogen sensitive and insensitive breast cancer cell lines, suggesting a molecular mechanism of action for inhibition of breast cancer (Duda, Kang, Archer, Meng, & Hodin, 2001 ). Rice and Murphy confirmed in vitro inhibition of breast cancer cells, and further identified potent inhibition by a combination of ginsenosides Rc and Rh2. The two compounds appear to act via different mechanisms, Rc inhibiting progression of the cell cycle and Rh2 showing cytotoxic activity (Murphy, 2002) . Further in vitro studies have elicited other potential molecular mechanisms, including induction of apoptosis through activation of a protease, and via protein kinase signaling pathways in cancer cells (King & Murphy, 2007) .
Other cancers
Polyacetylenes in P. quinquefolius are cytotoxic to leukemia cells (Fujimoto et al., 1992) . Ginsenosides Rg3 and Rh2 have been shown to inhibit DNA synthesis in prostate cancer cells, to induce cell detachment and to modulate protein kinases (H.-S. Kim et al., 2004) . Rg3 can also inhibit metastasis of ovarian cancer cells in vitro . Miller, Delorme, and Shan (2009) conducted studies on mice with viral-induced tumors (erythroleukemia). Mice that were given 40mg/d of the CNT-2000 extract survived up to 50% longer compared to controls. When human colon cancer cells were exposed to P. quinquefolius extracts, cell proliferation and cell cycle progression was inhibited, an effect which was associated with both ginsenosides and polysaccharides (King, & Murphy, 2010) .
Endocrine effects
The effect of ginseng on human hormones has long been a source of controversy. Laboratory investigations indicate ginsenoside Rb1 is an estrogen receptor agonist (Papapetropoulos, 2007) ; Leung et al., 2006) . P. quinquefolius extract has also been shown to activate estrogen receptors however the effect was shown to depend on the extraction solvent used -aqueous extractions (which are polysaccharide rich) provide no estrogenic activity (King, Adler, & Murphy , 2006) . Rg1 activates glucocorticoid receptors (Lee et al., 1997 ) however this does not necessarily imply the ginsenoside acts like a steroid hormone (Leung & Wong, 2010) . McElhaney et al. (2004) found that when COLD-fx was taken early in the "cold and flu" season the relative risk and duration of the common cold in a group of 43 elderly subjects was reduced compared to placebo by 48% and 55% respectively. In a larger trial of 323 subjects aged 18-65 years, the mean number of colds in the ginseng group was significantly reduced compared to the placebo group; severity of symptoms was reduced and the duration was also reduced by 2.4 days -these results are comparable to those of common antiviral drugs used for treatment of influenza (Predy et al., 2005) .
Clinical Trials
Common cold
Recently in a systemic review of five randomized clinical trials (four using COLD-fx, one Ginsana G-115-P. ginseng), the authors noted a consistent trend towards a lower risk of developing the common cold and evidence in two trials (both COLD-fx) that duration of colds and other acute respiratory infections was reduced by an average of six days. They concluded however that there is insufficient evidence to recommend ginseng extracts for prevention of the common cold (Seida, Durec, & Kuhle, 2009 ).
Memory and cognition
Recently an acute randomized double-blinded clinical study of 32 healthy young adults demonstrated significant improvement in working memory and other cognitive measures following ingestion of varying doses of P. quinquefolius extract (Cereboost TM ) standardized to 11.65% ginsenosides (Scholey et al., 2010) .
Cancer
A randomized double-blind pilot study was conducted on 290 adult patients with a history of cancer-related fatigue, who were given ascending doses of 4-year old Wisconsin grown P. quinquefolius over eight weeks. The groups who received doses of 1,000 and 2000 mg daily appeared to have less fatigue compared to the group taking a placebo, as assessed by various validated scales (Barton et al., 2009) . By contrast a randomized controlled crossover trial of ten healthy males given 1,125mg of CNT-2000 (a proprietary extract also known as North American Ginseng Extract (NAGE) containing 10% ginsenosides daily for five weeks failed to show significant effects on immune response as assessed by changes to white blood cell levels, lymphocyte proliferation or neutrophil oxidative burst (Biondo et al., 2008) .
Modern Phytotherapy
Ginseng species are adaptogens -agents that increase general capacities to withstand situations of stress. P. quinquefolius is a noted adaptogen, inducing a reduction in stress and increase in physical performance over a period of time (Keville, 2000; Yarnell & Hooper, 2003) . These adaptogenic effects are thought to assist in stress reduction via an influence on the hypothalamicpituitary-adrenal (HPA) axis (Braun & Cohen 2010) . Modern clinical applications include hormone modulation for menopausal women, reduction and prevention of tumors in breast cancer patients and overall support for people living with HIV (Yarnell & Hooper, 2003) . Additional uses include improving cerebral circulation, reducing fatigue and supporting healthy heart function (Keville, 2000; Yarnell & Hooper, 2003) .
The main therapeutic actions and clinical indications for P. quinquefolius are listed in Table 4 . (Blumenthal, 2003; Green, 1991; Keville, 2000; Mills & Bone, 2000; Mitchell, 2003; Yarnell, Abascal, & Hooper 2003) . (Green, 1991) . With Avena sativa L. for nervous exhaustion
Combinations
Contraindications
Avoid in conditions manifested by acute inflammation or high fever or irritability. (Blumenthal, 2003; Keville, 2000; Yarnell et al., 2003) . Powder: 0.30-10.0 grams, three times daily. Decoction: 3-6g dried root simmered in 750-1000mL water. Tincture: 2-4ml 3x a day Standardized extract (5:1) -CNT2000: 2-300mg, 2-3 caps daily TCM dose: 1-9g (Bensky & Gamble, 1993) .
Preparations and Dosage
Safety and toxicity P. quinquefolius is generally regarded as a safe herb, and is categorized as Class 1: "herbs that can be safely consumed when used appropriately" by the Botanical Safety Handbook (McGuffin, Hobbs, Upton, & Goldberg, 1997) . Most of the literature concerning ginseng and safety is based on P. ginseng which is not a reliable predictor given known phytochemical differences between the two species (Kitts & Hu, 2000) . The National Toxicological Program performed short-term toxicity, long term carcinogenicity and genetic toxicology in vivo studies on ginseng species and found no evidence of toxicity (National Toxicology Program [NTP], 2004) . In a Phase II clinical trial of 75 children with existing respiratory tract infections, safety data was generated and no significant adverse events were reported (Vohra et al., 2008) . Charrios (2006) warns that the elderly may be at risk of exacerbating existing hypoglycaemia, and that diabetic subjects taking P. quinquefolius should monitor blood glucose more frequently. She also refers to potential "severe effects" of ginseng in general, but cites no examples or evidence (Charrios 2006). High doses do have the potential to cause nervousness or insomnia with both species (Jia et al., 2009) .
P. quinquefolius does not appear to significantly affect cytochrome P450 enzymes, hence the risk of negative drug-herb reactions is relatively low. An in vitro study indicated inhibition of CYP3A4 was dependent on overall ginsenoside levels, however there was no such correlation with CYP2C9 (Luu, Foster, McIntyre, Tam, & Arnason, 2011) . In one study on healthy human volunteers, a P. quinquefolius extract was combined with the HIV protease inhibitor drug Indinavir; there was no evidence of any pharmacokinetic interaction (Andriana et al., 2008) .
Regulatory Status
P. quinquefolius is regulated in the U.S.A. as a Dietary Supplement. In Canada it is regulated as Food, if no therapeutic claims are made, and New Drug if claims are made.
Sustainability Ecological status-RTE status
On a global scale, P. quinquefolius is listed as G3-G4. States vary in their assessment of the status of ginseng and not all states have up-to-date plant surveys. Connecticut, Minnesota, Massachussets, and North Carolina list P. quinquefolius as of "special concern", Pennsylvania as vulnerable, Michigan and New Hampshire as threatened and Rhode Island as endangered. Tennessee lists P. quinquefolius as commercially exploited and does not include P. quinquefolius in its standard environmental review process. Landowners are advised that harvest is not sustainable (Tennessee Natural Heritage Program, 2008) The Massachusetts DNR (n.d.) notes that across the nation, P quinquefolius is considered to be a locally threatened species because of over-harvesting, primarily for export to China. (See Appendix-1)
Harvesting & Collection regulations
The collection, cultivation and trade of P. quinquefolius is governed at the county, state and federal level. Continued approval for export from individual states is based on a determination by the U.S. Fish and Wildlife Service that exports will not be detrimental to the survival of the species. Herzog (2010) once ginseng has been grown and harvested from a field, it cannot be grown in that field again. 
Cultivation: Seeds
Ginseng begins to produce berries (each with two seeds) in the third year. These should be cold stratified and some sources suggest storing in damp sand for a year before planting. The law may require that seeds from wild-gathered plants be planted immediately in the area surrounding the original plants. Gathered seeds may be planted from the end of September until the end of February, and will germinate April/May. Plant seeds about 1/2" deep.
Cultivation: Roots
Ginseng does not reproduce vegetatively. Two-year old roots will produce berries the following fall.
Plant the roots about 1 1/2 inches deep, with the roots placed longways across the soil. Do not plant vertically. Cover the bed with mulch or rotten leaves.
Cultivation: Crop Treatments
Canada maintains a list of chemicals that are approved for use with ginseng. 1. "Glyphosate application is usually recommended in the first few weeks of April. For glyphosate to work properly, the weeds should be green and actively growing. However, it is important to ensure that no ginseng has emerged above the soil, or it could be damaged. There have also been reports in the past that glyphosate residues on the straw can damage ginseng if it emerges into the straw shortly after application. Closely examine the stage of ginseng emergence before applying glyphosate products" (Ontario Ministry of Agriculture, Food and Rural Affairs (OMAFRA), 2011.
2. "Quadris can be applied at any time and should be applied before ginseng begins to emerge for maximum protection from Rhizoctonia. Quadris can be extremely toxic to some varieties of apple and crabapple. Do not apply where there is the possibility of drift onto apple trees. Application before a rainfall will improve penetration of the product to the root zone" (OMAFRA, 2011).
3. "The first application of Bravo should be applied when the ginseng has 20% emerged.
For more information on ginseng pest management, consult OMAFRA Publication 610 -Production Recommendations for Ginseng" (OMAFRA, 2011) 4. OMFRA (2011) also lists the following as approved for 2011: 1) Switch 62.5 WG Fungicide for the control of Botrytis blight (Botrytis cinerea) and Alternaria leaf blight (Alternaria panax) on ginseng in Canada. Restrictions include: A maximum of two (2) applications per season can be made at an interval of 7 -10 days if conditions remain favourable for disease development. In general begin applications prior to or at the onset of disease. Do not apply within 7 days of harvest for ginseng.
2) Beleaf 50 SG Insecticide for the control of aphids. Allow a minimum of 7 days between applications. Do not apply more than 3 times per year.
Harvesting
Roots should be dug in the fall after the above-ground parts die back. Take care to dig the entire root with all of its branches. Wash as soon as possible, but do not scrub. 
Grower's Associations
Summary -some possibilities moving forward
More than any other herbal species, P. quinquefolius plays a significant role in the history, culture and economy of the Appalachian community. Until recently, research into therapeutic applications has been focused on the Asian counterpart (P. ginseng), however the last decade has seen a dramatic rise in the number of peer-reviewed publications investigating the biology, phytochemistry, pharmacology of the indigenous species, as well as clinic effects on humans. Initiatives such as the American Botanical Council"s Ginseng Evaluation Program (Hall et al., 2001 ) which help to set standards for ginseng products are increasingly likely to focus on P. quinquefolius.
To date investigators have tended to focus on ginsenoside levels and their ratios in determining herb quality, and linking different ginsenosides to certain biological activities. It seems likely that levels of other constituents such as polyacetylenes and polysaccharides also influence quality and efficacy of P. quinquefolius, and that more focus should be placed on the use of whole root preparations, as well as of other plant sections. Now that a body of evidence is accumulating from laboratory and animal studies including safety data, there is a need for more human studies focusing on the potential benefits for cognition and memory, metabolic impairment, stress, fatigue and immune deficient disorders.
